Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines

European Journal of Immunology

Volumn 34, Issue 12, 2004, Pages 3682-3689

  Panzer, Ulf ^a,b   Uguccioni, Mariagrazia ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Chemokines; Inflammation; Monocytes; Prostaglandin E2

Indexed keywords

ACTIN; CALCIUM; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RANTES; STROMAL CELL DERIVED FACTOR 1; SULPROSTONE; ISOPROTEIN;

ACTIN POLYMERIZATION; ARTICLE; CALCIUM MOBILIZATION; CELL FUNCTION; CELL INTERACTION; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; LEUKOCYTE MIGRATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL MOTION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ACTINS; CALCIUM; CELL MOVEMENT; CHEMOKINES; DINOPROSTONE; HUMANS; MONOCYTES; PROTEIN ISOFORMS; RECEPTORS, PROSTAGLANDIN E;

EID: 10944255153     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425226     Document Type: Article

References (33)

1. Goetzl, E. J., An, S. and Smith, W. L., Specifity of expression and effects of eicosanoid mediators in normal physiology and human disease. FASEB. J. 1995. 9: 1051-1058.
2. Griffiths, R., Prostaglandins and inflammation.In Galin, J. and Snyderman, R., (Eds.) Inflammation: basic principles and clinical correlates. Lippincott, Wiliams & Wilkins. Philiadelphia 1999, pp 349-360.
3. Tilley, S. L., Coffman, T. M. and Koller, B. H., Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 2001. 108: 15-23.
4. Harris, S. G., Padilla, J., Kouas, L., Ray, D. and Phipps, R. P., Prostaglandins as modulators of immunity. Trends Immunol. 2002. 23: 144-150.
5. Simon, L. S., Weaver, A. L., Graham, D. Y., Kivitz, A. J., Lipsky, P. E., Hubbard, R. C., Isakson, P. C., Verburg, K. M., Yu, S. S., Zhao, W. W. and Geis, G. S., Anti-inflammatory and gastrointerstinal effects of celecoxib in rheumatoid arthritis. A randomized controlled trial. JAMA 1999. 282: 1921-1928.
6. Narumiya, S., Sugimoto, Y. and Ushikubi, F., Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 1999. 79: 1193-1226.
7. Coleman, R. A., Smith, W. L. and Narumiya, S., VIII. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 1994. 46: 205-229.
8. Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y. and Narumiya, S., Ligand binding specifities of the eight types and subtypes of the mouse prostanoid receptors expressed in chinese hamster ovary cells. Br. J. Pharmacol. 1997. 122: 217-224.
9. Boie, Y., Stocco, R., Sawyer, N., Slipetz, D. M., Ungrin, M. D., Neuschafer-Rube, F., Puschel, G. P., Metters, K. M. and Abramovitz, M., Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur. J. Pharmaco. 1997. 340: 227-241.
10. Dormond, O., Foletti, A., Paroz, C. and Ruegg, C., NSAID inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nat. Med 2001. 7: 1041-1047.
11. 2: effects on corneal endothelial cell migration and monolayer spreading during wound repair in vitro. Current Eye Res. 1995. 14: 601-609.
12. 2 on mesangial cell migration. Am. J. Nephrol. 1995. 15: 300-305.
13. Rozic, J. G., Chakraborty, C. and Lala, P. K., Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int. J. Cancer. 2001. 93: 497-506.
14. Luft, T., Jefford, M., Luetjens, P., Toy, T, Hochrein, H., Mastermann, K. A., Maliszewski, C., Shortman, K., Cebon, J. and Maraskovsky, E., Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E regulates the migratory capacity of specific DC subsets. Blood 2002. 100: 1362-1372.
15. Scandella, E., Men, Y., Gillessen, S., Förster, R. and Groettrup, M., Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002. 100: 1354-1361.
16. Müller, W. A., New mechanisms and pathways for monocyte recruitment. J. Exp. Med. 2001. 194: 47-51.
17. Mazzarella, G., Petillo, O., Margarucci, S., Calabrese, C. and Peluso, G., Role of monocyte/macrophage population in immune response. Monaldi. Arch. Chest Dis. 1998. 53: 92-96.
18. Rot, A. and von Andrian, U. H., Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 2004. 22:1-29.
19. Luster, A. D., Chemokines-chemotactic cytokines that mediates inflammation. N. Engl. J. Med. 1998. 338:436-445.
20. Rossi, D. and Zlotnik, A., The biology of chemokines and their receptos. Annual. Rev. Immunol. 2000. 18: 217-242.
21. Baggiolini, M., Chemokines and leukocyte traffic. Nature 1998. 392: 565-568.
22. Thivierge, M., Le Gouill, C., Tremblay, M. J., Stankova, J. and Rola-Pleszczynski, M., Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: Downregualtion of CCR5 expression by cyclic adenosine monophosphate. Blood 1998. 92: 40-45.
23. Kurth, I., Willimann, K., Schaerli, P., Hunziker, T., Clark-Lewis, I. and Moser, B., Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med. 2001. 194: 855-861.
24. Coleman, R. A., Eglen, R. M., Jones, R. L., Narumiya, S., Shimizu, T., Smith, W. L., Dahlen, S. E. M., Drazen, J. M., Gardinet, P. J., Jackson, W. T., Jones, T. R., Krell, D. R. and Nicosia, S., Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. Ad. Prostaglandin Thromboxane Leukot. Res. 1995. 23: 283-285.
25. 2 subtype: cloning, expression, and northern blot analysis FEBS. Lett. 1995. 372: 151-156.
26. Scandella, E., Men, Y., Legler, D. F., Gillessen, S., Prikler, L., Ludewig, B. and Groettrup, M., CCL19/CCL21 triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 2004. 103: 1595-1601.
27. Sozzani S., Rieppi M., Locati M., Zhou D., Bussolino F., Proost P., Van Damme, J. and Mantovani, A., Synergism between platelet activating factor and C-C chemokines for arachidonate release in human monocytes. Biochem. Biophys. Res. Commun. 1994. 199: 761-766.
28. Clark-Lewis, I., Moser, B., Walz, A., Baggiolini, M., Scott, G. J. and Aebersold, R., Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide. Biochemistry 1991. 30: 3128-3135.
29. Breyer, R. M., Bagdassarian, C. K., Myers, S. A. and Breyer, M. D., Prostanoid receptors: subtypes and signaling. Annual. Rev. Pharmacol. Toxicol. 2001. 41: 661-690.
30. Ogilvie, P., Paoletti, S., Clark-Lewis, I., Uguccioni, M., Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. Blood 2003. 102: 789-794.
31. Von, T. V., Prod'horn, B., Baggiolini, M. and Reuter, H., Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. Nature 1986. 324: 369-372.
32. Uguccioni, M., D'Apuzzo, M., Loetscher, M., Dewald, B. and Baggiolini, M., Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J. Immunol. 1995. 25: 64-68.
33. Takayama, K., Garcia-Cardena, G., Sukhova, G.K., Comander, J., Gimbrone, M. A. and Libby, P., Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J. Biol. Chem. 2002. 277: 44147-44154.